AbbVie Inc. (ABBV)

AbbVie Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Nov 18, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	413,904	314,021	273,605	285,707	239,371	189,171
Market Cap Growth	16.29%	14.77%	-4.24%	19.36%	26.54%	44.48%
Enterprise Value	477,912	378,098	321,532	343,858	307,886	268,325
Last Close Price	234.00	171.70	144.45	144.79	116.76	88.17
PE Ratio	177.34	74.10	56.77	24.25	20.87	41.52
Forward PE	17.06	14.81	13.96	12.72	10.04	9.05
PS Ratio	6.94	5.57	5.04	4.92	4.26	4.13
PB Ratio	-	93.35	26.32	16.53	15.51	14.44
P/FCF Ratio	21.07	17.61	12.40	11.78	10.89	11.27
P/OCF Ratio	19.88	16.70	11.98	11.45	10.51	10.76
PEG Ratio	1.09	1.68	58.43	-	2.03	1.56
EV/Sales Ratio	8.01	6.71	5.92	5.92	5.48	5.86
EV/EBITDA Ratio	16.19	14.15	12.20	11.98	10.89	12.69
EV/EBIT Ratio	22.47	20.63	18.21	17.00	15.58	18.28
EV/FCF Ratio	24.28	21.20	14.57	14.18	14.00	15.98
Debt / Equity Ratio	-26.49	20.22	5.80	3.74	5.03	6.65
Debt / EBITDA Ratio	2.31	2.51	2.26	2.22	2.71	4.06
Debt / FCF Ratio	3.50	3.81	2.73	2.66	3.53	5.19
Asset Turnover	0.43	0.42	0.40	0.41	0.38	0.38
Inventory Turnover	3.63	4.03	4.36	4.93	5.38	5.96
Quick Ratio	0.47	0.43	0.63	0.69	0.56	0.60
Current Ratio	0.73	0.66	0.87	0.96	0.79	0.84
Return on Equity (ROE)	137.96%	62.29%	35.20%	72.40%	80.95%	187.69%
Return on Assets (ROA)	9.59%	8.49%	8.07%	8.86%	8.31%	7.65%
Return on Capital (ROIC)	18.50%	16.13%	14.47%	14.46%	12.78%	11.53%
Return on Capital Employed (ROCE)	22.50%	19.00%	18.20%	18.50%	17.70%	12.00%
Earnings Yield	0.57%	1.36%	1.78%	4.14%	4.82%	2.44%
FCF Yield	4.75%	5.68%	8.06%	8.49%	9.19%	8.88%
Dividend Yield	2.96%	3.66%	4.15%	3.94%	4.55%	5.49%
Payout Ratio	503.56%	257.71%	216.72%	84.85%	80.24%	167.16%
Buyback Yield / Dilution	-0.01%	-0.06%	0.28%	-0.06%	-6.22%	-12.74%
Total Shareholder Return	2.94%	3.61%	4.43%	3.89%	-1.67%	-7.25%

Updated Oct 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q